WASHINGTON--(BUSINESS WIRE)--BrainScope Company, Inc., developers of a new generation of non-invasive hand-held devices that are designed to quickly assess a patient’s brain function and potentially identify dysfunction to help medical professionals prescribe appropriate treatment, today announced several new initiatives to fuel its growth. Revolution LLC, Alafi Capital and ZG Ventures have increased their investment in the company, and BrainScope has named two new appointments to their senior executive team. In addition, the company announced it will be headquartered in the Washington, D.C. metropolitan area.
